Rapport Therapeutics Statistics
Total Valuation
RAPP has a market cap or net worth of $1.37 billion. The enterprise value is $987.28 million.
Important Dates
The last earnings date was Wednesday, November 4, 2026, before market open.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
RAPP has 59.28 million shares outstanding. The number of shares has increased by 31.77% in one year.
| Current Share Class | 59.28M |
| Shares Outstanding | 59.28M |
| Shares Change (YoY) | +31.77% |
| Shares Change (QoQ) | +0.62% |
| Owned by Insiders (%) | 3.39% |
| Owned by Institutions (%) | 66.92% |
| Float | 44.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 68.76 |
| Forward PS | 192,617.29 |
| PB Ratio | 2.85 |
| P/TBV Ratio | 3.52 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 49.48 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.07, with a Debt / Equity ratio of 0.02.
| Current Ratio | 20.07 |
| Quick Ratio | 19.47 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -33.33% and return on invested capital (ROIC) is -22.67%.
| Return on Equity (ROE) | -33.33% |
| Return on Assets (ROA) | -21.97% |
| Return on Invested Capital (ROIC) | -22.67% |
| Return on Capital Employed (ROCE) | -42.09% |
| Weighted Average Cost of Capital (WACC) | 11.88% |
| Revenue Per Employee | $238,095 |
| Profits Per Employee | -$1.79M |
| Employee Count | 84 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.84% in the last 52 weeks. The beta is 1.40, so RAPP's price volatility has been higher than the market average.
| Beta (5Y) | 1.40 |
| 52-Week Price Change | -13.84% |
| 50-Day Moving Average | 29.85 |
| 200-Day Moving Average | 35.51 |
| Relative Strength Index (RSI) | 37.28 |
| Average Volume (20 Days) | 1,091,215 |
Short Selling Information
The latest short interest is 3.96 million, so 6.67% of the outstanding shares have been sold short.
| Short Interest | 3.96M |
| Short Previous Month | 3.05M |
| Short % of Shares Out | 6.67% |
| Short % of Float | 8.82% |
| Short Ratio (days to cover) | 3.14 |
Income Statement
In the last 12 months, RAPP had revenue of $20.00 million and -$150.47 million in losses. Loss per share was -$3.18.
| Revenue | 20.00M |
| Gross Profit | -33.92M |
| Operating Income | -167.62M |
| Pretax Income | -150.47M |
| Net Income | -150.47M |
| EBITDA | -166.71M |
| EBIT | -167.62M |
| Loss Per Share | -$3.18 |
Full Income Statement Balance Sheet
The company has $395.03 million in cash and $9.39 million in debt, with a net cash position of $385.64 million or $6.51 per share.
| Cash & Cash Equivalents | 395.03M |
| Total Debt | 9.39M |
| Net Cash | 385.64M |
| Net Cash Per Share | $6.51 |
| Equity (Book Value) | 391.19M |
| Book Value Per Share | 8.13 |
| Working Capital | 387.08M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$120.85 million and capital expenditures -$333,000, giving a free cash flow of -$121.18 million.
| Operating Cash Flow | -120.85M |
| Capital Expenditures | -333,000 |
| Depreciation & Amortization | 902,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -121.18M |
| FCF Per Share | -$2.04 |
Full Cash Flow Statement Margins
| Gross Margin | -169.58% |
| Operating Margin | -838.08% |
| Pretax Margin | -752.35% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
RAPP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -31.77% |
| Shareholder Yield | -31.77% |
| Earnings Yield | -13.71% |
| FCF Yield | -8.81% |
Analyst Forecast
The average price target for RAPP is $64.21, which is 177.25% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $64.21 |
| Price Target Difference | 177.25% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RAPP has an Altman Z-Score of 34.17 and a Piotroski F-Score of 1.
| Altman Z-Score | 34.17 |
| Piotroski F-Score | 1 |